Twenty years' experience of rubella vaccination in Sweden: 10 years of selective vaccination (of 12-year-old girls and of women postpartum) and 13 years of a general two-dose vaccination

This publication has 13 references indexed in Scilit:

• The Elimination of Indigenous Measles, Mumps, and Rubella from Finland by a 12-Year, Two-Dose Vaccination Program
  New England Journal of Medicine, 1994
• Long-term follow-up study of rubella antibodies in naturally immune and vaccinated young adults
  Vaccine, 1994
• Changes of the immunological patterns against measles, mumps and rubella. A vaccination programme studied 3 to 7 years after the introduction of a two-dose schedule
  Vaccine, 1991
• Swedish experience of two dose vaccination programme aiming at eliminating measles, mumps, and rubella.
  BMJ, 1987
• Persistence of Vaccine-Induced Immune Responses to Rubella: Comparison with Natural Infection
  Clinical Infectious Diseases, 1985
• Standardization of Techniques and Reagents for the Study of Rubella Antibody
  Clinical Infectious Diseases, 1985
• Scandinavian model for eliminating measles, mumps, and rubella.
  BMJ, 1984
• Outcome of Rubella during Pregnancy with Special Reference to the 17th-24th Weeks of Gestation
  Scandinavian Journal of Infectious Diseases, 1983
• Mass vaccination programme aimed at eradicating measles, mumps, and rubella in Sweden: first experience.
  BMJ, 1983
• Experiences from vaccination and revaccination of teenage girls with three different rubella vaccines
  Journal of Biological Standardization, 1976